Effect of 0.5% povidone-iodine on the nasopharyngeal and oropharyngeal viral loads in patients with COVID-19: A double-blind placebo-controlled randomized clinical trial

BACKGROUND AND OBJECTIVE: The povidone-iodine (PvP-I) nasal antiseptic has been shown to completely inactivate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro at variable concentrations. This study was performed to investigate the effect of 0.5% PvP-I nasal drops and oral g...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Pranav, Singh, Amit, Singh, Naresh Pal, Takhelchangbam, Nilima, Kumar, Raj, Yadav, Ramakant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810934/
https://www.ncbi.nlm.nih.gov/pubmed/36618132
http://dx.doi.org/10.4103/jfmpc.jfmpc_446_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810934/
https://www.ncbi.nlm.nih.gov/pubmed/36618132
http://dx.doi.org/10.4103/jfmpc.jfmpc_446_22

Ejemplares similares